Has Deana Mercer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $901,494 in general payments to Deana Mercer, MD across 611 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deana Mercer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deana Mercer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deana Mercer, MD

Orthopaedic Surgery · Albuquerque, NMNPI 1275672263

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.0%), education and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Skeletal Dynamics Inc at 57.3% of the total. Among orthopaedic surgery clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$901,494in general payments, 2019–2025

Across 611 payments — averaging $1475.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Skeletal Dynamics Inc$517K
Axogen$363K
Checkpoint Surgical, Inc$12K
Endo Pharmaceuticals Inc.$7K
Smith+Nephew$423
Kerecis Limited$328
plus $1K from 11 others

$29,467in research payments, 2019–2025

Across 10 payments — averaging $2946.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Axogen$29K

What the payments were for

Royalty or licence$59,4767%
Consulting fees$109,75512%
Speaking & faculty fees$514,04457%
Travel & lodging$48,8785%
Food & beverage$36,7244%
Education$132,61815%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Skeletal Dynamics Inc	276	$516,810
Axogen	284	$363,203
Checkpoint Surgical, Inc	14	$12,387
Endo Pharmaceuticals Inc.	10	$7,132
Smith+Nephew	6	$423
Kerecis Limited	4	$328
FX Shoulder Solutions, Inc	2	$215
Stryker	2	$213
Endo USA, Inc.	2	$142
Zimmer Biomet	3	$136
Osteocentric Technologies, Inc.	2	$125
AbbVie	1	$122
Sonex Health, Inc.	1	$114
Johnson & Johnson	1	$66
Renerve Ltd	1	$30
Coopersurgical, Inc.	1	$26
My01 Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Geminus$512,821
Align$512,821
IJS$512,821
Implate$512,821
AVANCE NERVE GRAFT$225,381
AxoGuard Nerve Connector$194,010
AxoGuard Nerve Protector$194,010
AXOGUARD$125,447
AXOGUARD HA+ NERVE PROTECTOR$108,765
AxoGuard Nerve Cap$108,540
Checkpoint Stimulators$12,147
XIAFLEX$6,818
Kerecis SurgiClose$730
Kerecis GraftGuide$182
ACCOLADE$161
Conquest FN$126
NATRELLE SALINE-FILLED BREAST IMPLANTS$122
Sx-One Microknife$114
OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST$105
EVOS$104

How this compares

$901,494 in reported general payments places this provider in the 95th percentile of 107 orthopaedic surgery providers in New Mexico.

See all orthopaedic surgery providers in New Mexico →

Medicare billing

Part B allowed, 2024

$99,576

Medicare patients

217

Services billed

446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	19	$144

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Albuquerque

David ChafeyAlbuquerque$108K
Heather MenzerAlbuquerque$61K
Ernesto Otero LopezAlbuquerque$50K
Rick GehlertAlbuquerque$46K
Jeffrey BeckenbaughAlbuquerque$46K
Matthew WhartonAlbuquerque$22K
Jeffrey RaccaAlbuquerque$20K
Michael ArchibeckAlbuquerque$19K
Samer KakishAlbuquerque$15K
Matthew BrownAlbuquerque$11K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →